Companies / Deals
Cencora to buy American Oncology Network at a $2.4 billion enterprise value
The price is $2.3 billion at closing plus contingent rights of up to $100 million. The release raised the floor of its fiscal 2026 adjusted diluted EPS outlook to at least $17.90, from a prior $17.75 to $17.95 range.
